Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice

Journal of Bone and Mineral Research

Volumn 29, Issue 7, 2014, Pages 1627-1638

  Ohata, Yasuhisa ^a,b   Yamazaki, Miwa ^a   Kawai, Masanobu ^a   Tsugawa, Naoko ^c   Tachikawa, Kanako ^a   Koinuma, Tomoko ^a   Miyagawa, Kazuaki ^a   Kimoto, Akihito ^a   Nakayama, Masahiro ^a   Namba, Noriyuki ^b   Yamamoto, Hironori ^d   Okano, Toshio ^c   Ozono, Keiichi ^b   Michigami, Toshimi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

FGF23; GENETIC ANIMAL MODELS; OSTEOMALACIA AND RICKETS; SYSTEMS BIOLOGY BONE INTERACTORS; VITAMIN D

Indexed keywords

ALPHA KLOTHO; CYTOCHROME; CYTOCHROME P450 24A1; CYTOCHROME P450 27 B1; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR 1; KLOTHO PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VITAMIN D; BETA GLUCURONIDASE; CALCIDIOL 1 MONOOXYGENASE; CALCIUM; COLECALCIFEROL 24 HYDROXYLASE; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MINERAL; PHOSPHATE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; GENE TARGETING; HUMAN; HYPOPHOSPHATEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; ANIMAL; BLOOD; DRUG EFFECTS; EMBRYOLOGY; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FETOMATERNAL TRANSFUSION; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; ORGAN CULTURE TECHNIQUE; SIGNAL TRANSDUCTION; TIME;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; ANTIBODIES, NEUTRALIZING; CALCIUM; EARLY GROWTH RESPONSE PROTEIN 1; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FEMALE; FETUS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCURONIDASE; HUMANS; KIDNEY; MALE; MATERNAL-FETAL EXCHANGE; MICE; MINERALS; ORGAN CULTURE TECHNIQUES; PHOSPHATES; PLACENTA; PREGNANCY; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; VITAMIN D; VITAMIN D3 24-HYDROXYLASE;

EID: 84903287565     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2186     Document Type: Article

References (34)

1. Quarles LD., Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008; 118 (12): 3820-8.
2. Liu S, Zhou J, Tang W, et al. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006; 291 (1): E38-49.
3. Goetz R, Beenken A, Ibrahimi OA, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007; 27 (9): 3417-28.
4. Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004; 19 (3): 429-35.
5. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113 (4): 561-8.
6. Segawa H, Kawakami E, Kaneko I, et al. Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter. Pflugers Arch. 2003; 446 (5): 585-92.
7. Carpenter TO., New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin North Am. 1997; 44 (2): 443-66.
8. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995; 11 (2): 130-6.
9. Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003; 348 (17): 1656-63.
10. Endo I, Fukumoto S, Ozono K, et al. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone. 2008; 42 (6): 1235-9.
11. Beck L, Soumounou Y, Martel J, et al. Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest. 1997; 99 (6): 1200-9.
12. Sabbagh Y, Gauthier C, Tenenhouse HS., The X chromosome deletion in HYP mice extends into the intergenic region but does not include the SAT gene downstream from Phex. Cytogenet Genome Res. 2002; 99 (1-4): 344-9.
13. Liu S, Tang W, Zhou J, et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006; 17 (5): 1305-15.
14. Boskey A, Frank A, Fujimoto Y, et al. The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice. Calcif Tissue Int. 2009; 84 (2): 126-37.
15. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390 (6655): 45-51.
16. Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444 (7120): 770-4.
17. Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281 (10): 6120-3.
18. Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD., FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol. 2008; 19 (12): 2342-50.
19. Gattineni J, Bates C, Twombley K, et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009; 297 (2): F282-91.
20. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007; 117 (12): 4003-8.
21. Krajisnik T, Bjorklund P, Marsell R, et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol. 2007; 195 (1): 125-31.
22. Ohata Y, Arahori H, Namba N, et al. Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood. J Clin Endocrinol Metab. 2011; 96 (6): E943-7.
23. McClive PJ, Sinclair AH., Rapid DNA extraction and PCR-sexing of mouse embryos. Mol Reprod Dev. 2001; 60 (2): 225-6.
24. Strom TM, Francis F, Lorenz B, et al. Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet. 1997; 6 (2): 165-71.
25. Kovacs CS, Manley NR, Moseley JM, Martin TJ, Kronenberg HM., Fetal parathyroids are not required to maintain placental calcium transport. J Clin Invest. 2001; 107 (8): 1007-15.
26. Tsugawa N, Suhara Y, Kamao M, Okano T., Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem. 2005; 77 (9): 3001-7.
27. Higashi T, Awada D, Shimada K., Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biol Pharm Bull. 2001; 24 (7): 738-43.
28. Tomiyama K, Maeda R, Urakawa I, et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci USA. 2010; 107 (4): 1666-71.
29. Watson ED, Cross JC., Development of structures and transport functions in the mouse placenta. Physiology (Bethesda). 2005; 20: 180-93.
30. Kovacs CS, Woodland ML, Fudge NJ, Friel JK., The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. Am J Physiol Endocrinol Metab. 2005; 289 (1): E133-44.
31. Goetz R, Ohnishi M, Kir S, et al. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. J Biol Chem. 2012; 287 (34): 29134-46.
32. Rossant J, Cross JC., Placental development: lessons from mouse mutants. Nat Rev Genet. 2001; 2 (7): 538-48.
33. Takaiwa M, Aya K, Miyai T, et al. Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period. Bone. 2010; 47 (2): 256-62.
34. Minamitani K, Minagawa M, Yasuda T, Niimi H., Early detection of infants with hypophosphatemic vitamin D resistant rickets (HDRR). Endocr J. 1996; 43 (3): 339-43.